Work

Gemtuzumab Ozogamicin (MylotargR) as Primary Induction Therapy for Elderly Patients with Acute Myeloid Leukemia: A Phase II Trial.

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.4508.4508

Authors: Lisa A. Kujawski, Elaina M. Gartner, Irene Ryan, Kent Griffith, Harry P. Erba

Institution: University of Michigan

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589503393

FWCI:

Cites:

Cited by:

Related to: 10